Literature DB >> 30653734

The association between lifestyle factors and Parkinson's disease progression and mortality.

Kimberly C Paul1, Yu-Hsuan Chuang1, I-Fan Shih1, Adrienne Keener2, Yvette Bordelon2, Jeff M Bronstein2, Beate Ritz1,2.   

Abstract

BACKGROUND: Lifestyle factors may contribute to the development of Parkinson's disease, but little is known about factors that influence progression. The objective of the current study was to examine whether caffeine or alcohol consumption, physical activity, or cigarette smoking is associated with progression and survival among PD patients.
METHODS: We assessed lifelong coffee, tea, and alcohol consumption, smoking, and physical activity in a prospective community-based cohort (n = 360). All patients were passively followed for mortality (2001-2016); 244 were actively followed on average ± SD 5.3 ± 2.1 years (2007-2014). Movement disorder specialists repeatedly assessed motor function (Hoehn & Yahr) and cognition (Mini-Mental State Exam). We used Cox proportional hazards models and inverse probability weights to account for censoring.
RESULTS: Coffee, caffeinated tea, moderate alcohol consumption, and physical activity were protective against at least 1 outcome. Smoking and heavy alcohol consumption were associated with increased risks. Coffee was protective against time to Hoehn & Yahr stage 3 (hazard ratio, 0.52; 95% confidence interval, 0.28-1.01), cognitive decline (hazard ratio, 0.23; 95% confidence interval, 0.11, 0.48), and mortality (hazard ratio, 0.47; 95% confidence interval, 0.32-0.69). Relative to moderate drinkers, those who never drank liquor and those who drank more heavily were at an increased risk of Hoehn & Yahr 3 (hazard ratio, 3.48; 95% confidence interval, 1.90-6.38; and hazard ratio, 2.16; 95% confidence interval, 1.03, 4.54, respectively). A history of competitive sports was protective against cognitive decline (hazard ratio, 0.46; 95% confidence interval, 0.22-0.96) and Hoehn & Yahr 3 (hazard ratio, 0.42; 95% confidence interval, 0.23-0.79), as was physical activity measured by metabolic-equivalent hours. Current cigarette smoking was associated with faster cognitive decline (hazard ratio, 3.20; 95% confidence interval, 1.02-10.01).
CONCLUSIONS: This population-based study suggests that lifestyle factors influence PD progression and mortality.
© 2019 International Parkinson and Movement Disorder Society. © 2019 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Parkinson's disease; alcohol; coffee; cognition; progression

Mesh:

Substances:

Year:  2019        PMID: 30653734      PMCID: PMC6544143          DOI: 10.1002/mds.27577

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  32 in total

1.  The effect of cigarette smoking, tea, and coffee consumption on the progression of Parkinson's disease.

Authors:  Boris Kandinov; Nir Giladi; Amos D Korczyn
Journal:  Parkinsonism Relat Disord       Date:  2007-02-01       Impact factor: 4.891

Review 2.  The epidemiology of Parkinson's disease: risk factors and prevention.

Authors:  Alberto Ascherio; Michael A Schwarzschild
Journal:  Lancet Neurol       Date:  2016-10-11       Impact factor: 44.182

3.  Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease.

Authors:  J F Chen; K Xu; J P Petzer; R Staal; Y H Xu; M Beilstein; P K Sonsalla; K Castagnoli; N Castagnoli; M A Schwarzschild
Journal:  J Neurosci       Date:  2001-05-15       Impact factor: 6.167

4.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

5.  Impact of paper filtered coffee on oxidative DNA-damage: results of a clinical trial.

Authors:  Miroslav Mišík; Christine Hoelzl; Karl-Heinz Wagner; Christophe Cavin; Beate Moser; Michael Kundi; Tanja Simic; Leonilla Elbling; Nina Kager; Franziska Ferk; Veronika Ehrlich; Armen Nersesyan; Maria Dušinská; Benoît Schilter; Siegfried Knasmüller
Journal:  Mutat Res       Date:  2010-08-13       Impact factor: 2.433

6.  Parkinson's disease risk from ambient exposure to pesticides.

Authors:  Anthony Wang; Sadie Costello; Myles Cockburn; Xinbo Zhang; Jeff Bronstein; Beate Ritz
Journal:  Eur J Epidemiol       Date:  2011-04-20       Impact factor: 8.082

7.  Neuroprotective and Therapeutic Effect of Caffeine on the Rat Model of Parkinson's Disease Induced by Rotenone.

Authors:  Yasser A Khadrawy; Ahmed M Salem; Karima A El-Shamy; Emad K Ahmed; Nevein N Fadl; Eman N Hosny
Journal:  J Diet Suppl       Date:  2017-02-13

Review 8.  Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence.

Authors:  M Hamer; Y Chida
Journal:  Psychol Med       Date:  2008-06-23       Impact factor: 7.723

9.  α-Synuclein genetic variants predict faster motor symptom progression in idiopathic Parkinson disease.

Authors:  Beate Ritz; Shannon L Rhodes; Yvette Bordelon; Jeff Bronstein
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

10.  Alcohol Consumption, Types of Alcohol, and Parkinson's Disease.

Authors:  Rui Liu; Xuguang Guo; Yikyung Park; Jian Wang; Xuemei Huang; Albert Hollenbeck; Aaron Blair; Honglei Chen
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

View more
  25 in total

Review 1.  The microbiome-gut-brain axis in Parkinson disease - from basic research to the clinic.

Authors:  Ai Huey Tan; Shen Yang Lim; Anthony E Lang
Journal:  Nat Rev Neurol       Date:  2022-06-24       Impact factor: 44.711

2.  Predicting Motor Responsiveness to Deep Brain Stimulation with Machine Learning.

Authors:  Kevin J Krause; Fenna Phibbs; Thomas Davis; Daniel Fabbri
Journal:  AMIA Annu Symp Proc       Date:  2022-02-21

3.  Physical activity and risk of Parkinson's disease and parkinsonism in a prospective population-based study (NEDICES).

Authors:  Sara Llamas-Velasco; Israel Contador; Antonio Méndez-Guerrero; Carmen Romero Ferreiro; Julián Benito-León; Alberto Villarejo-Galende; Félix Bermejo-Pareja
Journal:  Prev Med Rep       Date:  2021-07-08

4.  Coffee, smoking and aspirin are associated with age at onset in idiopathic Parkinson's disease.

Authors:  Carolin Gabbert; Inke R König; Theresa Lüth; Beke Kolms; Meike Kasten; Eva-Juliane Vollstedt; Alexander Balck; Anne Grünewald; Christine Klein; Joanne Trinh
Journal:  J Neurol       Date:  2022-03-02       Impact factor: 6.682

Review 5.  Chasing Protection in Parkinson's Disease: Does Exercise Reduce Risk and Progression?

Authors:  Grace F Crotty; Michael A Schwarzschild
Journal:  Front Aging Neurosci       Date:  2020-06-19       Impact factor: 5.750

6.  Irritable bowel syndrome and subsequent risk of Parkinson's disease: a nationwide population-based matched-cohort study.

Authors:  Mun Kyung Sunwoo; Yong Wook Kim; Seo Yeon Yoon; Jaeyong Shin; Seok-Jae Heo; Jee Suk Chang
Journal:  J Neurol       Date:  2021-07-13       Impact factor: 4.849

Review 7.  Cognitive Impairment in Parkinson's Disease: Epidemiology, Clinical Profile, Protective and Risk Factors.

Authors:  Paulina Gonzalez-Latapi; Ece Bayram; Irene Litvan; Connie Marras
Journal:  Behav Sci (Basel)       Date:  2021-05-13

8.  Decreased Risk of Parkinson's Disease After Rheumatoid Arthritis Diagnosis: A Nested Case-Control Study with Matched Cases and Controls.

Authors:  Jonas Bacelis; Michele Compagno; Sonia George; J Andrew Pospisilik; Patrik Brundin; Åsa Torinsson Naluai; Lena Brundin
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

Review 9.  Role of Alcohol Drinking in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.

Authors:  Bin Peng; Qiang Yang; Rachna B Joshi; Yuancai Liu; Mohammed Akbar; Byoung-Joon Song; Shuanhu Zhou; Xin Wang
Journal:  Int J Mol Sci       Date:  2020-03-27       Impact factor: 5.923

10.  Poststroke Parkinsonism associates with an increased mortality risk in patients.

Authors:  Dorji Harnod; Tomor Harnod; Cheng-Li Lin; Chung Y Hsu; Chia-Hung Kao
Journal:  Ann Transl Med       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.